Site-Specific Treatment and Remission Patterns in Multisite Mucous Membrane Pemphigoid
Study limitation reported by the research below: “JAK inhibitor serious adverse events are noted but the specific agents and dosing are not detailed in the abstract, limiting safety interpretation.”